ES461200A1 - Un procedimiento para la preparacion de un compuesto de cia-noprostaglandina farmaceuticamente activo. - Google Patents

Un procedimiento para la preparacion de un compuesto de cia-noprostaglandina farmaceuticamente activo.

Info

Publication number
ES461200A1
ES461200A1 ES461200A ES461200A ES461200A1 ES 461200 A1 ES461200 A1 ES 461200A1 ES 461200 A ES461200 A ES 461200A ES 461200 A ES461200 A ES 461200A ES 461200 A1 ES461200 A1 ES 461200A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutically active
noprostaglandin
cia
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461200A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES461200A1 publication Critical patent/ES461200A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES461200A 1976-08-06 1977-07-30 Un procedimiento para la preparacion de un compuesto de cia-noprostaglandina farmaceuticamente activo. Expired ES461200A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/712,361 US4045465A (en) 1976-08-06 1976-08-06 Cyanoprostaglandins

Publications (1)

Publication Number Publication Date
ES461200A1 true ES461200A1 (es) 1978-05-01

Family

ID=24861791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461200A Expired ES461200A1 (es) 1976-08-06 1977-07-30 Un procedimiento para la preparacion de un compuesto de cia-noprostaglandina farmaceuticamente activo.

Country Status (15)

Country Link
US (3) US4045465A (enExample)
JP (1) JPS5321121A (enExample)
BE (1) BE857535A (enExample)
DE (1) DE2733976A1 (enExample)
DK (1) DK345677A (enExample)
ES (1) ES461200A1 (enExample)
FI (1) FI772328A7 (enExample)
FR (1) FR2372156B1 (enExample)
GB (1) GB1553556A (enExample)
IE (1) IE45549B1 (enExample)
IL (1) IL52562A0 (enExample)
LU (1) LU77928A1 (enExample)
NL (1) NL169312C (enExample)
PT (1) PT66862B (enExample)
SE (1) SE7708124L (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125556A (en) * 1977-05-19 1978-11-14 The Dow Chemical Company Synthesis of 11-deoxyprostaglandins
DE2733680A1 (de) * 1977-07-26 1979-02-08 Bayer Ag Neue prostaglandin-analoga und verfahren zu ihrer herstellung
AU605813B2 (en) * 1986-11-21 1991-01-24 Santa Barbara Research Center Powder discharge apparatus
JP6145356B2 (ja) * 2013-08-07 2017-06-07 矢崎総業株式会社 電線保護部材

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723423A (en) * 1971-01-22 1973-03-27 Alza Corp Novel alkoxytetrahydropyranol ethers of prostaglandins
US3853854A (en) * 1971-06-24 1974-12-10 Alza Corp Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers
US3870747A (en) * 1971-11-24 1975-03-11 Merck & Co Inc Intermediates and process for prostaglandin synthesis
BE795589A (fr) * 1972-02-18 1973-08-16 May & Baker Ltd Derives du cyclopentane
US3890351A (en) * 1972-05-08 1975-06-17 Merck & Co Inc Loweralkyl esters of 3{62 -{8 tri(lower alkyl)silyloxy{9 -2{60 -(3-oxo or hydroxy-1-octenyl)-5-oxo-1{62 -cyclopentane-heptanoic acid, 5-cyclic ethylene acetal

Also Published As

Publication number Publication date
FR2372156B1 (enExample) 1984-04-06
US4078021A (en) 1978-03-07
FR2372156A1 (enExample) 1978-06-23
US4045465A (en) 1977-08-30
SE7708124L (sv) 1978-02-07
JPS5757032B2 (enExample) 1982-12-02
NL169312C (nl) 1982-07-01
IL52562A0 (en) 1977-10-31
PT66862A (en) 1977-08-01
DK345677A (da) 1978-02-07
JPS5321121A (en) 1978-02-27
FI772328A7 (enExample) 1978-02-07
NL7708471A (nl) 1978-02-08
GB1553556A (en) 1979-09-26
US4074044A (en) 1978-02-14
PT66862B (en) 1978-12-29
LU77928A1 (fr) 1979-05-23
NL169312B (nl) 1982-02-01
IE45549L (en) 1978-02-06
BE857535A (fr) 1978-02-06
IE45549B1 (en) 1982-09-22
DE2733976A1 (de) 1978-02-09

Similar Documents

Publication Publication Date Title
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES452764A1 (es) Procedimiento para la preparacion de nuevos 2-tetrahidrofur-furil-6, 7-benzomorfanos disustituidos en 5,9-beta.
ES429540A1 (es) Procedimiento para la obtencion de acidos fosfonicos.
SE7610177L (sv) Sett att sterilisera hanstandarknappar
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
ES394370A1 (es) Procedimiento para la preparacion de derivados de la inso-indolina.
ES438931A1 (es) Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.
ES473925A1 (es) Un procedimiento para la preparacion de un oligopeptido
ES470745A1 (es) Un procedimiento para preparar derivados de 6,6'-oxibis-pi- rona halo-sustituida
ES418924A1 (es) Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas.
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
SE7708553L (sv) Antibakteriell munvardskomposition
ES461200A1 (es) Un procedimiento para la preparacion de un compuesto de cia-noprostaglandina farmaceuticamente activo.
ES411112A1 (es) Procedimiento de preparacion de nuevos derivados del 1'1- difenil-etileno.
ES435197A1 (es) Procedimiento para preparar derivados de triazina.
ES326448A1 (es) Procedimiento de obtencion de una composicion terapeutica de accion mucolitica.
ES464045A1 (es) Un procedimiento para la produccion de una gamma-pirona.
ES433816A1 (es) Procedimiento para preparar derivados de amidoxina.
ES389473A1 (es) Un procedimiento de preparacion de derivados de aminocarbo-nil-3 oxazolidinona-2.
ES461691A1 (es) Un procedimiento para la preparacion de sales de compuestos.
ES462890A1 (es) Procedimiento para la preparacion de 1-(n-acil-carbamoil)-2-cianazi-ridinas con efecto cancerostatico y estimulador de inmunidad.
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ATE116856T1 (de) Prostacyclinderivate enthaltende mittel für die topische anwendung.
ES453787A1 (es) Un procedimiento para la preparacion de compuestos de nido- lina.
ES454657A1 (es) Procedimiento para preparar derivados de acidos 3,3'-tria- rilmetanodicarboxilicos.